SO
CMPX icon

STRS Ohio’s Compass Therapeutics CMPX Stock Holding History

STRS Ohio’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,900
Closed -$62.6K – 2196
2025
Q3 		$62.6K Hold
17,900
– – ﹤0.01% 1958
2025
Q2 		$46.5K Hold
17,900
– – ﹤0.01% 2034
2025
Q1 		$34K Hold
17,900
– – ﹤0.01% 1807
2024
Q4 		$26K Hold
17,900
– – ﹤0.01% 1794
2024
Q3 		$32.9K Hold
17,900
– – ﹤0.01% 1853
2024
Q2 		$17.9K Hold
17,900
– – ﹤0.01% 1897
2024
Q1 		$35K Sell
17,900
-1,100
-6% -$1.9K ﹤0.01% 1803
2023
Q4 		$29K Hold
19,000
– – ﹤0.01% 1827
2023
Q3 		$37K Hold
19,000
– – ﹤0.01% 1828
2023
Q2 		$60K Buy
+19,000
New +$59.7K ﹤0.01% 1789

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

STRS Ohio's CMPX Position: Q4 2025 in Review

STRS Ohio sold out of Compass Therapeutics (CMPX) in Q4 2025, closing a stake of 17,900 shares — an estimated $62.6K sold.

STRS Ohio first reported a position in CMPX in Q2 2023 and held it in 10 quarters. The position peaked at $62.6K in Q3 2025. 173 funds tracked by Wall St. Rank hold CMPX as of Q4 2025.

  • STRS Ohio reported no remaining Compass Therapeutics position as of Q4 2025 after selling out during the quarter.
  • STRS Ohio sold 17,900 Compass Therapeutics shares in Q4 2025, an estimated $62.6K.
  • STRS Ohio first reported a position in Compass Therapeutics in Q2 2023 and held it in 10 quarters.
  • STRS Ohio's Compass Therapeutics position peaked at $62.6K in Q3 2025.
  • 173 funds tracked by Wall St. Rank held Compass Therapeutics as of Q4 2025.

Based on STRS Ohio's 13F filing for Q4 2025, filed 2 Feb 2026.